Effectiveness of urokinase for salvaging occluded central venous access devices
Kelsey Dyson-Fleming Nursing student, Royal Manchester Children’s Hospital
Fibrinolytic drugs, such as urokinase, are used as a first line of action to clear the blockage, yet the effectiveness of fibrinolytic drugs is uncertain. Salvaging occluded central venous access devices (CVADs) prevents the patient needing a replacement, which would be inserted as a surgical procedure. Side effects and costs associated with inserting a new CVAD are higher than those for instilling urokinase.
Nursing Children and Young People.
30, 2, 20-20.
doi: 10.7748/ncyp.30.2.20.s20
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Are you a student? Our student subscription has content especially for you.
Find out more
